1. FDA. FDA Guidelines for the Format and Content of the Clinical and Statistical Sections of a New Drug Application. FDA, Rockville, MD, U.S.A., 1988.
2. The New Drug Approvals of 1996, 1997, and 1998: Drug Development Trends in the User Fee Era
3. Negotiating the gray maze: the business of medicine in Japan, 1997.
4. (eds). Proceedings of the First International Conference on Harmonisation. Queen's University of Belfast, 1992.
5. The value and benefits of ICH to industry. International Conference on Harmonisation for Registration of Pharmaceuticals for Human Use, IFPMA, PhRMA, 2000.